Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
about
PAK as a therapeutic target in gastric cancerGastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in ratsSomatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypesRole of AMP-18 in oral mucositisProliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.Glycine-extended gastrin induces matrix metalloproteinase-1- and -3-mediated invasion of human colon cancer cells through type I collagen gel and Matrigel.
P2860
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@en
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@nl
type
label
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@en
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@nl
prefLabel
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@en
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@nl
P2093
P2860
P1476
Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
@en
P2093
T Murayama
T Taniguchi
Y Matsumori
P2860
P304
P356
10.1111/J.1349-7006.1996.TB00287.X
P577
1996-07-01T00:00:00Z